Literature review reveals the involvement of co-receptors 2B4 and CD48 in allergic airway diseases, highlighting their potential as therapeutic targets for eosinophilic inflammation.
Eosinophils have a pivotal role in the pathogenesis of allergic airway disorders. They express a variety of receptors involved in their activation. Recently, the role of the CD2 Ig superfamily of receptors in eosinophilic inflammation, especially 2B4 and CD48, has been explored in allergic rhinitis and asthma. In recent years, there has been increasing evidence suggesting that these two molecules have an important role in allergic airway disorders. In this article, the most recently acquired data on the role of CD48 and 2B4 in allergic airway disorders are reviewed.
No takes yet. Share an insight, caveat, or question.
Ashqar et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: